TerminatedNCT05551195
[Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression]
Device studyAges 22–45United States
Understand this study
Who could participate?
Listed age limits: 22 years to 45 years.
- Listed locations
- Lafayette and 7 more locationsSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 16, 2022
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 7
- Sponsor
- Woebot Health
- Sponsor type
- Unknown or unclear
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 22 Years to 45 Years
- Official registry ID
- NCT05551195
- Official title
Show the full official title
A Multicenter, Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to Treatment as Usual Among Women With Mild to Moderate Postpartum Depression
Recruitment & locations
TerminatedLafayette · Santa Ana · DeLand
5 more locations
- Miami Lakes
- Seminole
- Decatur
- Glen Oaks
- Cleveland
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Woebot Health.
Who can participate?
Listed age limits: 22 years to 45 years.
Is this study still recruiting?
The registry lists this study as terminated.
